Why the study?
Does heparin reduce adverse fetal effects compared to oral anticoagulants in pregnant patients requiring anticoagulation?
Does heparin reduce adverse fetal effects compared to oral anticoagulants in pregnant patients requiring anticoagulation?
Heparin is the preferred anticoagulant during pregnancy due to its established fetal safety profile compared to oral anticoagulants, with specific dosing strategies required for patients with prosthetic heart valves.
Answers are grounded in this paper and cite their sources.
Supports heparin preference in pregnancy to limit fetal risk; leaves open optimal regimens for prosthetic valves.
Anticoagulant therapy during pregnancy is problematic because both heparin and oral anticoagulants can potentially produce adverse maternal and fetal effects. Reviewing the relevant literature makes it clear that heparin is safer for the fetus than are oral anticoagulants. For the prophylaxis and treatment of venous thromboembolic disease in pregnant patients, heparin is the preferred anticoagulant because its efficacy and safety are established. However, because the efficacy of heparin in preventing systemic embolism in patients with prosthetic heart valves is not established, either adjusted-dose heparin or a combination of heparin and oral anticoagulants can be used.
No takes yet. Share an insight, caveat, or question.
Ginsberg et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: